Abstract:Since their identification over twenty-five years ago, the plethora of cell-penetrating peptides (CPP) and their applications has skyrocketed. These 5 to 30 amino acid in length peptides have the unique property of breaching the cell membrane barrier while carrying cargoes larger than themselves into cells in an intact, functional form. CPPs can be conjugated to fluorophores, activatable probes, radioisotopes or contrast agents for imaging tissues, such as tumors. There is no singular mechanism for translocation of CPPs into a cell, and therefore, many CPPs are taken up by a multitude of cell types, creating the challenge of tumor-specific translocation and hindering clinical effectiveness. Varying strategies have been developed to combat this issue and enhance their diagnostic potential by derivatizing CPPs for better targeting by constructing specific cell-activated forms. These methods are currently being used to image integrin-expressing tumors, breast cancer cells, human histiocytic lymphoma and protease-secreting fibrosarcoma cells, to name a few. Additionally, identifying safe, effective therapeutics for malignant tumors has long been an active area of research. CPPs can circumvent many of the complications found in treating cancer with conventional therapeutics by targeted delivery of drugs into tumors, thereby decreasing off-target side effects, a feat not achievable by currently employed conventional chemotherapeutics. Myriad types of chemotherapeutics such as tyrosine kinase inhibitors, antitumor antibodies and nanoparticles can be functionally attached to these peptides, leading to the possibility of delivering established and novel cancer therapeutics directly to tumor tissue. While much research is needed to overcome potential issues with these peptides, they offer a significant advancement over current mechanisms to treat cancer. In this review, we present a brief overview of the research, leading to identification of CPPs with a comprehensive state-of-the-art review on the role of these novel peptides in both cancer diagnostics as well as therapeutics.

Cytoplasmic Transduction Peptide Mediated Protein Transduction Technology and Its Application in Medical Field

Protein transduction technology: a novel therapeutic perspective

Intracellular Delivery of Native Proteins Facilitated by Cell-Penetrating Poly(disulfide)s.

Cell Penetrating Peptides, Novel Vectors for Gene Therapy

Recent Advances of Cell-Penetrating Peptides and Their Application as Vectors for Delivery of Peptide and Protein-Based Cargo Molecules

Protein Transduction Technique and Its Application in Neuroprotection

Cell-Penetrating Peptides, Electroporation, and Drug Delivery

Cell-penetrating peptide: a means of breaking through the physiological barriers of different tissues and organs

Cardiac-Targeting Peptide: From Discovery to Applications

[Advances in the research and application of cell penetrating peptides]

Cell-Penetrating Peptides: Applications in Tumor Diagnosis and Therapeutics

Cell-Penetrating Peptides for Use in Development of Transgenic Plants

Advancement and application of novel cell-penetrating peptide in cancer management

Penetrating peptides: Applications in drug delivery

Cell-Penetrating Peptides: A Powerful Tool for Targeted Drug Delivery

Applications of amphipathic and cationic cyclic cell-penetrating peptides: Significant therapeutic delivery tool

Improvement of Cellular Adenovirus Uptake with TAT Peptide is Cell-type Dependent

Beyond Transduction: Anti-Inflammatory Effects of Cell Penetrating Peptides

The role of cell‐penetrating peptides in potential anti‐cancer therapy

Biological Activity Study on High Efficient Human-derived Cell-penetrating Peptide

Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application